Amniocentesis News and Research

RSS

Biocell Center participates in ‘Society for Maternal-Fetal Medicine’ meeting

Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.

9 Feb 2010

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).

5 Feb 2010

Biocell Center collaborates with Innovative Medical Solutions to preserve amniotic fluid stem cells

Preservation of amniotic fluid stem cells is an innovative technology that recently became available to expecting mothers in the United States with Biocell Center having launched its pioneering service here following its success in Europe.

2 Feb 2010

Combination of saliva test with ultra high-tech biopsy process may help prevent genetic disorders

Florida's largest fertility clinic announced it is the first in the state to offer promising new tests against birth defects: a coupling of technologies that will allow couples to avoid passing along more than 100 genetic diseases to their newborn.

22 Jan 2010

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Current use of prenatal ultrasounds in women with singleton pregnancies is 55% greater than in 1996, even in low-risk pregnancies. More than one-third (37%) of pregnant women now receive 3 or more ultrasound tests in the second and third trimesters of a given pregnancy, found an article http://www.cmaj.ca/embargo/cmaj090979.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

6 Jan 2010

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

The addition of a "genetic sonogram" maximizes the accuracy of non-invasive testing for Down syndrome, said a Baylor College of Medicine researcher who was lead author of a landmark study in the current issue of Obstetrics and Gynecology.

21 Nov 2009

Prenatal testing helps to bring down the birth rate of babies with Down syndrome

With new prenatal tests for Down syndrome on the horizon promising to be safer, more accurate, and available to women earlier in pregnancy, the medical community must come together and engage in dialogue about the impact of existing and expected tests, argues a new leading article published Online First by Archives of Disease in Childhood.

14 Sep 2009

QIAGEN launches novel product enabling non-invasive prenatal diagnostics and cancer detection

QIAGEN today announced the launch of a novel product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. Scientists consider these DNA and RNA fragments to have great potential for the highly sensitive and non-invasive diagnosis of a wide range of diseases, including congenital disorders, malignancies such as colon and lung cancer, and infections.

From QIAGEN Manchester Limited 25 May 2009

Amniotic fluid may be a new source of stem cells

For the first time, scientists have shown that amniotic fluid (the protective liquid surrounding an embryo) may be a potential new source of stem cells for therapeutic applications. The study was prepublished online on February 12, 2009, in Blood, the official journal of the American Society of Hematology.

31 Mar 2009

Breakthrough in prenatal screening for Down syndrome

Lenetix, Inc. today announced a significant step in the development of an improved first and second trimester non-invasive fetal chromosomal screening test to detect Down syndrome and other genetic fetal conditions.

29 Jan 2009

Possible test for autism raises calls for an ethical debate

New research by British scientists means prenatal testing for autism is a possibility, but has evoked calls for an ethical debate on the issue.

12 Jan 2009

Microarray analysis improves prenatal diagnosis

A "chip" or array that can quickly detect disorders such as Down syndrome or other diseases associated with chromosomal abnormalities proved an effective tool in prenatal diagnosis in a series of 300 cases at Baylor College of Medicine, said researchers in a report that appears in the current issue of the journal Prenatal Diagnosis.

17 Nov 2008

New non-invasive prenatal blood test for Down's syndrome, safer for the fetus

American researchers have created a prenatal blood test which can be used to determine if an unborn baby has Down's syndrome and the new test is safer for the fetus.

7 Oct 2008

Researchers examine human embryonic stem cell genome

Stem cell researchers from UCLA used a high resolution technique to examine the genome, or total DNA content, of a pair of human embryonic stem cell lines and found that while both lines could form neurons, the lines had differences in the numbers of certain genes that could control such things as individual traits and disease susceptibility.

31 Mar 2008

What's in a name? Labels like 'normal' and 'abnormal' on test results can affect patients' medical decisions

Patients whose physicians place labels on their test results - such as normal or abnormal, positive or negative - are inclined to make different decisions about their health care than those who receive the same results solely in terms of numbers and other quantifiable measures, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

5 Nov 2007

Experts discuss pioneering non-invasive test to determine the blood type of unborn babies

Experts from across the world will meet to discuss the implementation of a pioneering non-invasive test to determine the blood type of unborn babies at an event hosted by the University of Warwick.

25 Sep 2007

Rapid testing for pre-natal detection of Down syndrome

Scientists in California are reporting an advance toward rapid testing for pre-natal detection of Down syndrome and other birth defects that involve an abnormal number of chromosomes.

18 Sep 2007

Noninvasive screening in early pregnancy reduces Down's births by 50 percent

Non-invasive screening of pregnant women with ultrasound early in pregnancy, combined with maternal blood analysis, has reduced the number of children born in Denmark with Down Syndrome by 50%, a scientist will tell the annual conference of the European Society of Human Genetics today.

19 Jun 2007

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

The researchers performed high resolution MRS on 15 amniotic fluid samples for evaluation of fetal lung maturity between 34 and 40 weeks gestation and were analyzed using trimethysilylpropionic acid (TSP) as a reference standard.

11 May 2007

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

8 May 2007

Amniocentesis News and Research

Biocell Center participates in ‘Society for Maternal-Fetal Medicine’ meeting

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Biocell Center collaborates with Innovative Medical Solutions to preserve amniotic fluid stem cells

Combination of saliva test with ultra high-tech biopsy process may help prevent genetic disorders

Study reveals multiple ultrasound scans are more pronounced in low-risk pregnancies

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

Prenatal testing helps to bring down the birth rate of babies with Down syndrome

QIAGEN launches novel product enabling non-invasive prenatal diagnostics and cancer detection

Amniotic fluid may be a new source of stem cells

Breakthrough in prenatal screening for Down syndrome

Possible test for autism raises calls for an ethical debate

Microarray analysis improves prenatal diagnosis

New non-invasive prenatal blood test for Down's syndrome, safer for the fetus

Researchers examine human embryonic stem cell genome

What's in a name? Labels like 'normal' and 'abnormal' on test results can affect patients' medical decisions

Experts discuss pioneering non-invasive test to determine the blood type of unborn babies

Rapid testing for pre-natal detection of Down syndrome

Noninvasive screening in early pregnancy reduces Down's births by 50 percent

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News